Literature DB >> 29648949

Induced Systemic Resistance Against Citrus Canker Disease by Rhizobacteria.

Nadia Riera1, Han Wang1, Yong Li1, Jinyun Li1, Kirsten Pelz-Stelinski1, Nian Wang1.   

Abstract

Citrus canker, caused by Xanthomonas citri subsp. citri, is an important citrus disease that causes significant economic losses worldwide. All commercial citrus varieties are susceptible to citrus canker. Currently, chemical control with copper based products is the main approach to control X. citri subsp. citri dispersal and plant colonization. However, extensive use of copper compounds can result in copper-resistant strains and cause adverse effects on the environment. Alternatives to chemical control involve the activation of citrus immunity to control the disease. Here, we investigated the ability of multiple rhizobacteria to induce a systemic defense response in cultivar Duncan grapefruit. Burkholderia territorii strain A63, Burkholderia metallica strain A53, and Pseudomonas geniculata strain 95 were found to effectively activate plant defense and significantly reduce symptom development in leaves challenged with X. citri subsp. citri. In the priming phase, root application of P. geniculata induced the expression of salicylic acid (SA)-signaling pathway marker genes (PR1, PR2, PR5, and salicylic acid carboxyl methyltransferase [SAM-SACM]). Gene expression analyses after X. citri subsp. citri challenge showed that root inoculation with P. geniculata strain 95 increased the relative levels of phenylalanine ammonia lyase 1 and SAM-SACM, two genes involved in the phenylpropanoid pathway as well as the biosynthesis of SA and methyl salicylate (MeSA), respectively. However, hormone analyses by UPLC-MS/MS showed no significant difference between SA in P. geniculata-treated plants and control plants at 8 days post-beneficial bacteria root inoculation. Moreover, P. geniculata root-treated plants contained higher reactive oxygen species levels in aerial tissues than control plants 8 days post-treatment application. This study demonstrates that rhizobacteria can modulate citrus immunity resulting in a systemic defense response against X. citri subsp. citri under greenhouse conditions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29648949     DOI: 10.1094/PHYTO-07-17-0244-R

Source DB:  PubMed          Journal:  Phytopathology        ISSN: 0031-949X            Impact factor:   4.025


  5 in total

Review 1.  Mechanistic insights into host adaptation, virulence and epidemiology of the phytopathogen Xanthomonas.

Authors:  Shi-Qi An; Neha Potnis; Max Dow; Frank-Jörg Vorhölter; Yong-Qiang He; Anke Becker; Doron Teper; Yi Li; Nian Wang; Leonidas Bleris; Ji-Liang Tang
Journal:  FEMS Microbiol Rev       Date:  2020-01-01       Impact factor: 16.408

2.  A Fluorescent Reporter-Based Evaluation Assay for Antibacterial Components Against Xanthomonas citri subsp. citri.

Authors:  Yunfei Long; Ruifang Luo; Zhou Xu; Shuyuan Cheng; Ling Li; Haijie Ma; Minli Bao; Min Li; Zhigang Ouyang; Nian Wang; Shuo Duan
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 6.064

3.  Identification of Appropriate Reference Genes for Normalizing miRNA Expression in Citrus Infected by Xanthomonas citri subsp. citri.

Authors:  Shiheng Lyu; Ying Yu; Shirong Xu; Weiwei Cai; Guixin Chen; Jianjun Chen; Dongming Pan; Wenqin She
Journal:  Genes (Basel)       Date:  2019-12-23       Impact factor: 4.096

4.  Natural variations of TFIIAγ gene and LOB1 promoter contribute to citrus canker disease resistance in Atalantia buxifolia.

Authors:  Xiaomei Tang; Xia Wang; Yue Huang; Ling Ma; Xiaolin Jiang; Muhammad Junaid Rao; Yuantao Xu; Ping Yin; Meng Yuan; Xiuxin Deng; Qiang Xu
Journal:  PLoS Genet       Date:  2021-01-25       Impact factor: 5.917

5.  The mode of action of plant associated Burkholderia against grey mould disease in grapevine revealed through traits and genomic analyses.

Authors:  Qassim Esmaeel; Cédric Jacquard; Lisa Sanchez; Christophe Clément; Essaid Ait Barka
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.